- AMGN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
Amgen (AMGN) 10-Q/A2015 Q2 Quarterly report (amended)
Filed: 6 Aug 15, 12:00am
Exhibit 31
CERTIFICATIONS
I, Robert A. Bradway, Chairman of the Board, Chief Executive Officer and President of Amgen Inc., certify that:
1. | I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q/A of Amgen Inc.; and |
2. | Based on my knowledge, this Amendment No. 1 does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Amendment No. 1. |
Date: August 6, 2015 | /s/ Robert A. Bradway | |
Robert A. Bradway | ||
Chairman of the Board, | ||
Chief Executive Officer and President |
CERTIFICATIONS
I, David W. Meline, Executive Vice President and Chief Financial Officer of Amgen Inc., certify that:
1. | I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q/A of Amgen Inc.; and |
2. | Based on my knowledge, this Amendment No. 1 does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Amendment No. 1. |
Date: August 6, 2015 | /s/ David W. Meline | |
David W. Meline | ||
Executive Vice President and Chief Financial Officer |